Kapil Cotex Ltd 52 Week High

Kapil Cotex Ltd 52 Week High

Image

Skybiotech Healthcare Limited

NSE: SKYBIOTECH

YEARHIGH

₹ 237.3

Last updated on: Jul 28, 2026

Key Highlights

  • The 52 Week HIGH of Skybiotech Healthcare Limited is ₹ 237.3 as of 28 Jul 26 .

Company Fundamentals for Skybiotech Healthcare Limited

Market Price of Skybiotech Healthcare Limited

1M

1Y

3Y

5Y

Monitoring Skybiotech Healthcare Limited share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Jul 2026167
27 Jul 2026168
24 Jul 2026160.15
23 Jul 2026157
22 Jul 2026149.85
21 Jul 2026142.75
20 Jul 2026136
17 Jul 2026130
16 Jul 2026136.8
15 Jul 2026144

Asset Value vs Market Value of Skybiotech Healthcare Limited

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Skybiotech Healthcare Limited

No data available

* All values are in crore

Historical Net Profit of Skybiotech Healthcare Limited

No data available

* All values are in crore

Skybiotech Healthcare Limited News Hub

Kapil Cotex reports standalone net profit of Rs 0.25 crore in the June 2024 quarter

Net profit of Kapil Cotex reported to Rs 0.25 crore in the quarter ended June 2024 as against net lo

Read more

16 Aug 24

Kapil Cotex to conduct AGM

Kapil Cotex announced that the 41th Annual General Meeting (AGM) of the company will be held on 30 S

Read more

18 Sept 24

Kapil Cotex announces board meeting date

Kapil Cotex will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powered

Read more

11 Nov 24

Kapil Cotex reports standalone net profit of Rs 0.01 crore in the September 2024 quarter

Net profit of Kapil Cotex remain constant at Rs 0.01 crore in the quarter ended September 2024 and a

Read more

15 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Skybiotech Healthcare Limited

What is the significance of Skybiotech Healthcare Limited reaching its 52-week high?

Skybiotech Healthcare Limited reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Skybiotech Healthcare Limited 52-week high?

Investors monitor Skybiotech Healthcare Limited 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Skybiotech Healthcare Limited a good buy when it hits its 52-week high?

Whether Skybiotech Healthcare Limited is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Skybiotech Healthcare Limited fundamentals.

What should I consider before investing in Skybiotech Healthcare Limited at its 52-week high?

Before investing in Skybiotech Healthcare Limited at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Skybiotech Healthcare Limited stock price continue to rise after reaching its 52-week high?

Skybiotech Healthcare Limited stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions